In a time of increasingly individualized healthcare, Elizabeth Philp has emerged as a significant force of innovation, notably in the tech-driven field of compounded pharmacy. As the co-founder and CEO of Roseway Labs, Philp is at the forefront of a push to make custom medications more accessible, disrupting the standard one-size-fits-all approach